Drug class in one race
GLP-1/GIP receptor (dual) drugs for Obesity
12 tracked GLP-1/GIP receptor (dual) drugs in the Obesity race. The class explanation lives on the GLP-1/GIP receptor (dual) page; the full indication pipeline across every mechanism is on the Obesity page.
1 approved / phase 47 Phase 33 Phase 21 Phase 1
Head-to-head evidence: BGM0504 vs Brenipatide · BGM0504 vs HDM1005 · BGM0504 vs HS-20094 · BGM0504 vs NNC0519-0130 · BGM0504 vs RAY1225 · BGM0504 vs THDBH120